Lp(a) Lipoprotein and Plasminogen Activity in Patients with Different Etiology of Ischemic Stroke

Publisher： Karger

E-ISSN： 1421-9786|23|2-3|188-193

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.23, Iss.2-3, 2006-12, pp. : 188-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein-Associated Phospholipase A2 Activity Is Associated with Large-Artery Atherosclerotic Etiology and Recurrent Stroke in TIA Patients

By  

Cerebrovascular Diseases, Vol. 33, Iss. 2, 2011-12 ,pp. : 150-158

Karger

Access to resources Recommend Favorite

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Frequency and Predictors of Symptomatic Intracerebral Hemorrhage in Patients with Ischemic Stroke Treated with Recombinant Tissue Plasminogen Activator outside Clinical Trials

By  

Cerebrovascular Diseases, Vol. 23, Iss. 2-3, 2006-11 ,pp. : 85-90

Karger

Access to resources Recommend Favorite

Effects of Uric Acid Levels on Outcome in Severe Ischemic Stroke Patients Treated with Intravenous Recombinant Tissue Plasminogen Activator

By  

European Neurology, Vol. 71, Iss. 3-4, 2013-12 ,pp. : 132-139

Karger

Access to resources Recommend Favorite

Risk Factor, Pattern, Etiology and Outcome in Ischemic Stroke Patients with Cancer: A Nested Case-Control Study

By  

Cerebrovascular Diseases, Vol. 23, Iss. 2-3, 2006-12 ,pp. : 181-187

Karger

Access to resources Recommend Favorite